NDC 11673-840 – Guaifenesin
Guaifenesin 1200 mg/1 · Tablet · Oral
Product NDC11673-840
Product details
- Brand name
- Guaifenesin
- Generic name
- Guaifenesin
- Labeler
- TARGET CORPORATION
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA213420
- Marketed since
- August 1, 2024
- Listing expires
- December 31, 2026
- Pharmacologic class
- Expectorant
Active ingredients
- Guaifenesin 1200 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 11673-840-27 | 14 TABLET in 1 BLISTER PACK (11673-840-27) | Aug 1, 2024 |
| 11673-840-28 | 28 TABLET in 1 BLISTER PACK (11673-840-28) | Aug 1, 2024 |
Other Guaifenesin products
- 80513-413 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Advanced Rx LLC
- 60687-874 Guaifenesin 300 mg/15mL · Solution · American Health Packaging
- 60687-863 Guaifenesin 200 mg/10mL · Solution · American Health Packaging
- 60687-852 Guaifenesin 100 mg/5mL · Solution · American Health Packaging
- 46122-750 Guaifenesin 600 mg/1 · Tablet, Extended Release · AMERISOURCE BERGEN
- 65162-036 Guaifenesin 600 mg/1 · Tablet, Extended Release · Amneal Pharmaceuticals LLC
- 65162-037 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Amneal Pharmaceuticals LLC
- 24689-144 Guaifenesin 400 mg/1 · Tablet · APNAR PHARMA LP
- 58602-810 Guaifenesin 600 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-853 Guaifenesin 600 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-864 Guaifenesin 600 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-865 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Aurohealth LLC